One of the methods for predicting LT outcome is the Metroticket 2.0 model, which is based on the level of alpha-fetoprotein (AFP), tumor size, and tumor number and allows the prediction of the risk of death from HCC-related factors after LT. This evidence concerns the gene AFP and hepatocellular carcinoma.